SeaStar Medical Holding Corp financial data

Symbol
ICU, ICUCW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
3513 Brighton Blvd, Suite 410, Denver, CO
State of incorporation
Colorado
Fiscal year end
December 31
Former names
LMF Acquisition Opportunities Inc (to 10/27/2022)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 27.5 % -85%
Debt-to-equity -142 % -17.5%
Return On Equity 316 % +146%
Return On Assets -757 % -1014%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.22M shares -82.7%
Common Stock, Shares, Outstanding 1.9M shares -89.5%
Entity Public Float 23.6M USD
Common Stock, Value, Issued 1K USD -50%
Weighted Average Number of Shares Outstanding, Basic 3.15M shares +428%
Weighted Average Number of Shares Outstanding, Diluted 3.15M shares +428%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.29M USD +19.6%
General and Administrative Expense 8.21M USD -20.8%
Operating Income (Loss) -14.5M USD +18.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -32.6M USD -64.6%
Income Tax Expense (Benefit) -2K USD -133%
Net Income (Loss) Attributable to Parent -32.6M USD -64.5%
Earnings Per Share, Basic 2.21 USD/shares +74.9%
Earnings Per Share, Diluted 2.21 USD/shares +74.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash, Cash Equivalents, and Short-term Investments 0 USD
Assets, Current 2.41M USD +95.8%
Assets 3.47M USD +33.6%
Accounts Payable, Current 4.12M USD -5.47%
Accrued Liabilities, Current 2.26M USD +66.5%
Contract with Customer, Liability, Current 112K USD
Liabilities, Current 9.93M USD -30.8%
Contract with Customer, Liability, Noncurrent 438K USD
Liabilities 10.4M USD -27.8%
Retained Earnings (Accumulated Deficit) -131M USD -33.3%
Stockholders' Equity Attributable to Parent -6.9M USD +41.3%
Liabilities and Equity 3.47M USD +33.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.49M USD -52%
Net Cash Provided by (Used in) Financing Activities 8.33M USD +180%
Common Stock, Shares Authorized 500M shares +400%
Common Stock, Shares, Issued 3.22M shares -82.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.18M USD +8969%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 25.6M USD +20.5%
Deferred Tax Assets, Gross 25.6M USD +20.5%
Deferred Tax Assets, Operating Loss Carryforwards 21.9M USD +17.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 124M USD +43.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 41K USD -92.6%
Interest Expense 648K USD -30.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares